Premium
Controlled fed‐batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen
Author(s) -
Hsieh JihHan,
Shih KunYu,
Kung HsiangFu,
Shiang Ming,
Lee LanYing,
Meng MengHsiao,
Chang ChingChuan,
Lin HuiMin,
Shih ShuChing,
Lee ShuYing,
Chow TehYuan,
Feng TengYung,
Kuo TsongTeh,
Choo KongBung
Publication year - 1988
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.260320310
Subject(s) - hbsag , fermentation , yeast , saccharomyces cerevisiae , dehydrogenase , alcohol dehydrogenase , biology , biochemistry , antigen , strain (injury) , acid phosphatase , chemistry , microbiology and biotechnology , enzyme , virology , hepatitis b virus , immunology , virus , anatomy
We have performed controlled fed‐batch fermentation experiments to compare the production level of hepatitis B surface antigen (HBsAg) by recombinant yeast Saccharomyces cerevisiae strains (YNN27/pYBH‐1, YNN27/ p2μ‐S11, YNN27/pDCB‐S2) containing plasmid vector with alcohol dehydrogenase (ADH1), acid phosphatase (PHO5), and glyceraldehyde‐3‐phosphate dehydrogenase (GPD) promoter, respectively. Yeast cell concentrations of 15‐35 g dry cell weight/L were obtained. By limiting phosphorous concentration, HBsAg expression level for the YNN27/p2μ‐S11 strain with inducible PHO5 promoter reached 0.2–0.3 mg/L. By controlling nutrient addition rate and dissolved oxygen concentration, HBsAg concentrations of 3‐10 mg/L were achieved in 60–70 h fermentation using the YNN27/pDCB‐S2 strain with the constitutive GPD promoter.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom